000 | 01845 a2200529 4500 | ||
---|---|---|---|
005 | 20250514075458.0 | ||
264 | 0 | _c20030923 | |
008 | 200309s 0 0 eng d | ||
022 | _a0030-2414 | ||
024 | 7 |
_a10.1159/000072342 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTsuda, Hiroshi | |
245 | 0 | 0 |
_aAlteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium. _h[electronic resource] |
260 |
_bOncology _c2003 |
||
300 |
_a159-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
650 | 0 | 4 |
_aCDC2 Protein Kinase _xanalysis |
650 | 0 | 4 |
_aCell Cycle Proteins _xanalysis |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xchemistry |
650 | 0 | 4 | _aCheckpoint Kinase 2 |
650 | 0 | 4 |
_aCyclin B _xanalysis |
650 | 0 | 4 | _aCyclin B1 |
650 | 0 | 4 | _aDNA-Binding Proteins |
650 | 0 | 4 |
_aEndometrial Neoplasms _xchemistry |
650 | 0 | 4 |
_aEndometrium _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aG2 Phase |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHyperplasia |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPolymorphism, Single-Stranded Conformational |
650 | 0 | 4 |
_aProtein Kinases _xanalysis |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xanalysis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
650 | 0 | 4 | _aTumor Suppressor Proteins |
650 | 0 | 4 |
_acdc25 Phosphatases _xanalysis |
700 | 1 | _aHashiguchi, Yasunori | |
700 | 1 | _aInoue, Takeshi | |
700 | 1 | _aYamamoto, Kumio | |
773 | 0 |
_tOncology _gvol. 65 _gno. 2 _gp. 159-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000072342 _zAvailable from publisher's website |
999 |
_c12702668 _d12702668 |